Elidia Dewitt, NP
Family · Baton Rouge, LANPI 1982607420
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $107,251 of the $107,663 with a category attached, or 99.6%. Gilead accounts for 100.0% of it on its own, with 3 other manufacturers making up the rest. Reporting peaked in 2023 at $50,372 and has fallen 100.0% since, to $13 in 2024. Among family clinicians in LA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 12 payments — averaging $8971.89 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Gilead$108K
- Chiesi USA, Inc.$14
- Pfizer$13
- Genentech USA, Inc.$13
What the payments were for
- Consulting fees$107,251100%
- Food & beverage$4120%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Gilead | 9 | $107,623 |
| Chiesi USA, Inc. | 1 | $14 |
| Pfizer | 1 | $13 |
| Genentech USA, Inc. | 1 | $13 |
How this compares
$107,663 in reported general payments places this provider in the 95th percentile of 3,610 family providers in Louisiana.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Cefdinir | 55 | $782 |
| Azelastine Hcl | 30 | $580 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 19 | $545 |
| Doxycycline Monohydrate | 40 | $505 |
| Sucralfate | 17 | $207 |
| Methylprednisolone | 28 | $186 |
| Cephalexin | 24 | $155 |
| Mupirocin | 19 | $154 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 33 | $129 |
| Methocarbamol | 27 | $63 |
| Azithromycin | 14 | $63 |
| Pantoprazole Sodium | 17 | $57 |
| Ciprofloxacin Hcl | 12 | $54 |
| Ondansetron Hcl | 12 | $37 |
| Meclizine Hcl | 11 | $34 |
Paid to pharmacies, not to this prescriber.
Other family in Baton Rouge
- Ghenet GhebretatiosBaton Rouge$91K
- Heather SullivanBaton Rouge$32K
- Randee KidderBaton Rouge$30K
- Dionne BellBaton Rouge$24K
- Jennifer LittleBaton Rouge$21K
- Tracy ParkerBaton Rouge$19K
- Kristen VillarBaton Rouge$18K
- Sharon JacksonBaton Rouge$15K
- Gloria MarchandBaton Rouge$14K
- Stephanie ThomasBaton Rouge$14K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.